Department of Mathematics, Keio University, Yokohama, Japan.
The Institute of Mathematical Science, Tokyo, Japan.
Stat Med. 2019 Jun 30;38(14):2589-2604. doi: 10.1002/sim.8135. Epub 2019 Mar 12.
The predictive performance of biomarkers is a central concern in biomedical research. This is often evaluated by comparing two statistical models: a "new" model incorporating additional biomarkers and an "old" model without them. In 2008, the integrated discrimination improvement (IDI) was proposed for cases when the response variable is binary, and it is now widely applied as a promising alternative to conventional measures, such as the difference of the area under the receiver operating characteristic curve. However, the IDI can erroneously identify a significant improvement in the new model even if no additional information has been provided by new biomarkers. In order to overcome problems with existing measures, in this study, we propose the power-IDI as a measure of incremental predictive value. Our study explains why the IDI cannot avoid false detection of apparent improvements in a new model and we show that our proposed measure is better able to capture improvements in prediction. Numerical simulations and examples using real empirical data reveal that the power-IDI is not only more powerful but also incurs fewer false detections of improvement.
生物标志物的预测性能是生物医学研究中的一个核心关注点。这通常通过比较两个统计模型来评估:一个包含额外生物标志物的“新”模型和一个没有它们的“旧”模型。2008 年,提出了综合判别改善(IDI),用于响应变量为二进制的情况,现在它被广泛应用为一种有前途的替代传统措施的方法,例如接收者操作特征曲线下面积的差异。然而,IDI 可能会错误地识别出新模型的显著改善,即使新生物标志物没有提供额外的信息。为了克服现有措施的问题,在本研究中,我们提出了功效 IDI 作为增量预测价值的度量。我们的研究解释了为什么 IDI 不能避免在新模型中错误检测到明显的改进,并且我们表明我们提出的度量能够更好地捕捉预测的改进。数值模拟和使用真实经验数据的示例表明,功效 IDI 不仅更强大,而且误报改进的情况更少。